[Federal Register Volume 83, Number 102 (Friday, May 25, 2018)]
[Notices]
[Pages 24317-24318]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-11298]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Service Administration
Advisory Commission on Childhood Vaccines
AGENCY: Health Resources and Service Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice of Advisory Committee meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Commission on Childhood Vaccines
(ACCV) will hold a public meeting. This meeting will be open to the
public.
DATES: Friday, June 15, 2018, from 10:00 a.m. to 2:00 p.m. ET.
ADDRESSES: The meeting is a teleconference and webinar. The conference
call-in number is 1-800-988-0218; passcode: 9302948. The webinar link
is https://hrsa.connectsolutions.com/accv/. Participants should call
and connect 15 minutes prior to the meeting in order for logistics to
be set up. If you have never attended an Adobe Connect meeting, please
test your connection using the following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and
get a quick overview by following URL: http://www.adobe.com/go/connectpro_overview.
FOR FURTHER INFORMATION CONTACT: Annie Herzog, Principal Staff Liaison,
Division of Injury Compensation Programs (DICP), Healthcare Systems
Bureau (HSB), HRSA, 5600 Fishers Lane, Room 08N146B, Rockville,
Maryland 20857; phone: (301) 443-6593; or email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The ACCV advises the Secretary on the implementation of
the Vaccine Injury Compensation Program (VICP). Other activities of the
ACCV include: Recommending changes to the Vaccine Injury table, at its
own initiative or as the result of the filing of a petition; advising
the Secretary on implementing section 2127 of the Public Health Service
Act (PHS Act) regarding
[[Page 24318]]
the need for childhood vaccination products that result in fewer or no
significant adverse reactions; surveying federal, state, and local
programs and activities related to gathering information on injuries
associated with the administration of childhood vaccines, including the
adverse reaction reporting requirements of section 2125 (b) of the PHS
Act; advising the Secretary on the methods of obtaining, compiling,
publishing, and using credible data related to the frequency and
severity of adverse reactions associated with childhood vaccines;
consulting on the development or revision of Vaccine Information
Statements; and recommending to the Director of the National Vaccine
Program research related to vaccine injuries which should be conducted
to carry out the VICP.
Agenda: During the June 15, 2018, meeting, agenda items may include
updates from DICP, Department of Justice (DOJ), National Vaccine
Program Office (NVPO), Immunization Safety Office (Centers for Disease
Control and Prevention), National Institute of Allergy and Infectious
Diseases (National Institutes of Health) and Center for Biologics,
Evaluation and Research (Food and Drug Administration). Information
about the ACCV, a roster of members, the meeting agenda, as well as
past meeting summaries, is located on the ACCV website: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html. Agenda
items are subject to change as priorities dictate.
Public Participation: Members of the public will have the
opportunity to provide comments. Oral comments will be honored in the
order they are requested and may be limited as time allows. Requests to
make oral comments or provide written comments to the ACCV should be
sent to Annie Herzog by June 5, 2018. Individuals who plan to
participate and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify Annie
Herzog, using the address and phone number above at least 10 days prior
to the meeting.
Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-11298 Filed 5-24-18; 8:45 am]
BILLING CODE 4165-15-P